Medicare Advantage plans just got a $25 billion gift from CMS. Here's what nobody's talking about: CMS finalized a 5.06% payment increase for 2026, more than double their initial proposal of 2.23%. That's a massive swing from cautious to generous in just a few months. The effective growth rate jumped from 5.93% to 9.04%. Think about that for a second. While hospitals struggle with razor-thin margins and physician practices face mounting administrative costs, MA plans are seeing their biggest windfall in years. This comes as the three-year phase-in of the 2024 CMS-HCC risk adjustment model reaches 100% implementation. Translation: Plans are getting better at documenting patient complexity, and CMS is rewarding them for it. But here's the disconnect: Patients aren't ...

Your FQHC just got a new mission, and it's not what you think. HRSA's FY 2026 grant competition dropped last week, and it's a complete 180 from previous years. Out: Health disparities initiatives, LGBTQ+ programs, DEI activities, housing-first homelessness strategies. In: Chronic disease prevention, nutrition programs, obesity management, environmental health, reducing medication overreliance. This isn't just a priority tweak. It's a fundamental restructuring of how 30 million Americans receive care. FQHCs serve 1 in 11 people nationwide. For many communities, they're the only healthcare option. Now these centers must rapidly pivot their entire service model while operating on razor-thin margins. The timing couldn't be worse: • 42% of FQHCs have less than 90 days of cash reserves • The Community ...

Your surgical supplies just became a national security issue. On March 11, Stryker Corporation, one of healthcare's largest medical device suppliers, fell victim to a devastating wiper cyberattack that destroyed data across 200,000 devices globally. The attackers didn't want money. They wanted chaos. Here's what happened: The pro-Iran hacktivist group Handala exploited Microsoft Intune to wipe Stryker's systems clean. Manufacturing halted. Shipping stopped. Orders couldn't be processed. Hospitals suddenly faced uncertainty about their medical device supply chain. 50 TB of data was exfiltrated before the wipe. Think about that for a moment. Stryker supplies critical surgical tools, orthopedic implants, and medical equipment to thousands of hospitals. When their systems went dark, it wasn't just an IT problem, it was a ...

Your CHC might be leaving millions on the table right now. HRSA just opened multiple grant opportunities for community health centers, and the clock is ticking. The Service Area Competition application closes March 16, 2026. Here's what most CHCs are missing: The funding landscape has fundamentally shifted. COVID funding that once supported operations? It's down to 1% of CHC revenue. Meanwhile, Section 330 grants now represent 70% of federal support for community health centers. But here's the opportunity everyone's overlooking: 📍 Service Area Competition (HRSA-26-007): Applications due March 16 📍 Ryan White Part C Capacity Building: Opens March 2, worth $115,000 per award 📍 Rural Residency Planning: Opens February 16 for workforce development 📍 Dental Services for Neurodevelopmental Disorders: Opens ...

One AI model just beat every specialist radiologist AI. And it might change how we think about medical AI forever. Published March 5 in NEJM AI, MedVersa's generalist model didn't just compete with specialist systems, it matched or exceeded them across report generation, segmentation, detection, and visual question-answering tasks. Here's what makes this groundbreaking: Specialist AI models are trained for one thing: chest X-rays, brain MRIs, mammograms. We've invested billions building separate tools for each imaging type. But MedVersa proves a single model can do it all. 📊 The implications are massive: • Lower implementation costs (one system vs. dozens) • Simplified workflows for radiologists • Faster deployment across health systems • Better cross-modality pattern recognition Think about what this ...

90 seconds to know if your brain tumor surgery worked. That's all it takes now. University of Michigan just changed brain cancer surgery forever with DeepGlioma, an AI that reads tumor genetics while you're still on the operating table. Here's why this matters: Gliomas kill. Median survival for these aggressive brain tumors? Just 18 months. Every second of surgery counts, every millimeter of tumor removed matters. But surgeons have been operating blind. They couldn't know the tumor's genetic makeup during surgery. They'd remove what they could see, close up, wait days for pathology, then discover they missed critical tissue or removed too much healthy brain. Not anymore. 🧠 DeepGlioma analyzes tissue in real-time using stimulated Raman histology 🧠 Predicts genetic ...

Your lab results just got a translator, and it speaks human. Quest Diagnostics dropped something game-changing last week: an AI companion that turns five years of your lab data into actual conversations you can understand. No more googling "what does high BUN mean" at 2 AM. The Quest AI Companion, powered by Google's Gemini, lives right in the MyQuest app where 27 million Americans already check their results. It analyzes trends, explains terminology, and even generates smart questions to ask your doctor. But here's what struck me most: Quest solved the trust problem that kills most health AI tools. Instead of asking patients to upload sensitive data to random chatbots, they built AI into the platform that already guards their ...

Finally, breast cancer screening that doesn't bankrupt you halfway through. Here's what just changed: As of January 2026, if your mammogram shows something suspicious, your follow-up ultrasound, MRI, or biopsy is now FREE under ACA plans. No copays. No deductibles. No surprise bills. 🎯 Why this matters: Before this change, women would get their free mammogram, only to face thousands in bills when they needed follow-up imaging. Many simply didn't go back. Imagine finding a potential issue, then having to choose between your mortgage payment and the MRI that could save your life. That's exactly what was happening to millions of women, especially those with dense breast tissue who routinely need additional screening. The numbers are staggering: • 40% of ...

AI just proved it can catch breast cancer we're missing. A groundbreaking Swedish trial of 100,000 women just delivered the evidence we've been waiting for. AI-supported mammography isn't just hype anymore. The numbers from The Lancet study are striking: 📊 The AI advantage: • 81% of cancers caught during screening (vs 74% standard) • 12% fewer interval cancers between screenings • 44% reduction in radiologist workload But here's what matters most: The AI group found 16% fewer invasive cancers, 21% fewer large tumors, and 27% fewer aggressive cancers. Think about that. We're not just finding more cancers, we're catching them when they're smaller, less aggressive, and more treatable. 💡 The workforce impact is equally compelling. With radiologist burnout at crisis ...